Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free radical generating enzymes are a broad functional class of enzymes, including NADPH oxidases (NOX), xanthine oxidase (XO), and myeloperoxidase (MPO), that facilitate the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) (Sies & Jones, 2020). These enzymes play vital roles in physiological processes such as the "respiratory burst" in phagocytes for pathogen destruction and the regulation of vascular tone and cellular signaling (Lambeth, 2004). However, their chronic overactivation leads to oxidative stress, which contributes significantly to the pathophysiology of cardiovascular diseases, neurodegeneration, and chronic inflammatory conditions (Forrester et al., 2018). Therapeutic strategies involve using specific inhibitors like allopurinol for XO in the treatment of gout or investigating NOX inhibitors like setanaxib for fibrotic and metabolic diseases (Kallenberg et al., 2022). A major challenge in targeting these enzymes is achieving sufficient selectivity to prevent the suppression of beneficial ROS-dependent immune responses and essential homeostatic signaling pathways (Meijles & Pagano, 2019).
Inhibition of specific enzymatic pathways (e.g., molybdenum-containing hydroxylases or heme-dependent peroxidases) to decrease the catalytic production of reactive oxygen species (ROS) or reactive nitrogen species (RNS), thereby mitigating oxidative stress-mediated tissue damage (PubMed: 29053303).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Free radical generating enzymes.